4//SEC Filing
RAY DEBANJAN 4
Accession 0001140361-18-035277
CIK 0001501989other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 8:55 PM ET
Size
11.9 KB
Accession
0001140361-18-035277
Insider Transaction Report
Form 4
RAY DEBANJAN
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2018-08-01+290→ 19,220 totalExercise: $1.45Exp: 2024-02-27→ Common Stock (290 underlying) - Exercise/Conversion
Common Stock
2018-08-01$1.26/sh+2,710$3,414→ 8,638 total - Sale
Common Stock
2018-08-01$26.05/sh−3,000$78,150→ 5,928 total - Exercise/Conversion
Common Stock
2018-08-01$1.45/sh+290$420→ 8,928 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-08-01+2,710→ 0 totalExercise: $1.26Exp: 2023-12-10→ Common Stock (2,710 underlying)
Footnotes (2)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]100% of the shares subject to the option are fully vested and exercisable.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001706863
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 8:55 PM ET
- Size
- 11.9 KB